Provocative Mesenteric Angiography for Obscure Gastrointestinal Hemorrhage: An Update on Outcomes, Safety, and

Teresa A Benvenuti1, Miriam Chisholm1, Brendan Cline1

  • 1Division of Interventional Radiology, Duke University Health System, Durham, North Carolina.

Abstract

Insights

Provocative mesenteric angiography (PMA) safely identified gastrointestinal bleeding in 27.3% of patients. Hematochezia and prior positive imaging studies predicted success, while melena with negative imaging did not.

Area of Science:

  • Gastroenterology
  • Interventional Radiology
  • Vascular Imaging

Background:

  • Occult gastrointestinal hemorrhage (GIB) presents diagnostic challenges.
  • Provocative mesenteric angiography (PMA) is a potential tool for diagnosing obscure GIB.
  • Assessing the safety and effectiveness of PMA is crucial.

Purpose of the Study:

  • To evaluate the safety and modest effectiveness of PMA in patients with occult GIB.
  • To identify predictors of successful PMA in inducing bleeding.

Main Methods:

  • Retrospective review of 119 PMAs in 109 patients over 22 years.
  • PMA involved transcatheter administration of tissue plasminogen activator (tPA) into mesenteric arteries.
  • Adverse events within 30 days were assessed.

Main Results:

  • Active extravasation was induced in 27.7% of PMAs.
  • Hematochezia and prior positive radiologic studies were significant predictors of positive PMA.
  • No major bleeding adverse events were observed.

Conclusions:

  • PMA has a modest positivity rate (27.3%) with a favorable safety profile.
  • Hematochezia and positive prior imaging studies predict successful bleeding provocation.
  • PMA is not recommended for patients with melena and negative imaging studies.